Clinical Investigation : Thoracic Cancer Penetration of Recommended Procedures for Lung Cancer Staging and Management in the United States Over 10 Years : A Quality Research in Radiation Oncology Survey
暂无分享,去创建一个
R. Komaki | B. Movsas | C. Langer | F. Kong | Xiong Wei | J. Wilson | J. Owen | C. Crozier | N. Khalid | Feng-Ming
[1] Benjamin Movsas,et al. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. , 2012, International journal of radiation oncology, biology, physics.
[2] Benjamin Movsas,et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. , 2011, Journal of the National Cancer Institute.
[3] B. Movsas,et al. Shifting the Focus to Practice Quality Improvement in Radiation Oncology , 2010, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.
[4] R. Weber,et al. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. , 2010, Archives of Otolaryngology - Head and Neck Surgery.
[5] Radhe Mohan,et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[6] M. Zelefsky,et al. Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer. , 2009, Journal of the American College of Radiology : JACR.
[7] R. Arriagada,et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. , 2009, The Lancet. Oncology.
[8] Charles R. Thomas,et al. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. , 2009, Lung cancer.
[9] K. Kahn,et al. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Mohammad Jahanzeb,et al. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Kahn,et al. Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Emanuel,et al. Patterns of care studies: creating "an environment of watchful concern". , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Ettinger,et al. Patterns of care survey (PCS) in locally advanced non-small cell lung cancer (LA-NSCLC) and limited small cell lung cancer (LD-SCLC): how well does current practice follow the literature? , 2003 .
[14] D. Ettinger,et al. Radiotherapy patterns of care study in lung carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J P Pignon,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. , 1999, The New England journal of medicine.
[17] R. Komaki,et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. , 1999, The New England journal of medicine.
[18] B. Jeremic,et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J P Pignon,et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.
[20] P. Warde,et al. Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung - A meta-analysis , 1990 .
[21] A. Donabedian,et al. Twenty Years of Research on the Quality of Medical Care , 1985, Evaluation & the health professions.